We are live on
!
Find out more
SAM
Strategy Asset Managers Portfolio holdings
AUM
$650M
Turnover
21.36%
1-Year Est. Return
25.51%
This Fund
S&P 500
This Quarter
Est. Return
-5.85%
1 Year Est. Return
+25.51%
3 Year Est. Return
+115.5%
5 Year Est. Return
+130.94%
10 Year Est. Return
+375.79%
AUM
$417M
AUM Growth
-$31.7M
(-7.1%)
Cap. Flow
-$2.58M
Cap. Flow
% of AUM
-0.62%
Top 10 Holdings %
Top 10 Hldgs %
26.43%
Holding
158
New
25
Increased
28
Reduced
58
Closed
26
Avg Time Held
1.5
years
Top 10 Avg Time Held
0.8
years
Top 20 Avg Time Held
1.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Diageo
DEO
|
+$8.17M |
| 2 |
Expedia Group
EXPE
|
+$2.51M |
| 3 |
Constellation Brands
STZ
|
+$2.45M |
| 4 |
Hormel Foods
HRL
|
+$2.45M |
| 5 |
AutoZone
AZO
|
+$2.39M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lockheed Martin
LMT
|
+$3.69M |
| 2 |
General Dynamics
GD
|
+$3.51M |
| 3 |
PPG Industries
PPG
|
+$3.39M |
| 4 |
3M
MMM
|
+$3.29M |
| 5 |
Allstate
ALL
|
+$3.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.45% |
| 2 | Technology | 14.31% |
| 3 | Industrials | 12.51% |
| 4 | Consumer Staples | 11.72% |
| 5 | Financials | 10.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
CVS Health
CVS
$118B
| $14.8M | 3.55% |
153,295
-1,994
| -1% | -$210K |
2013 Q2
9 quarters
|
|
|
2
Lockheed Martin
LMT
$123B
| $12M | 2.87% |
57,727
-18,141
| -24% | -$3.69M |
2013 Q2
9 quarters
|
|
3
Walt Disney
DIS
$191B
| $11.1M | 2.66% |
108,359
-1,837
| -2% | -$200K |
2013 Q2
9 quarters
|
|
4
Bristol-Myers Squibb
BMY
$124B
| $10.9M | 2.62% |
184,204
-2,858
| -2% | -$181K |
2013 Q2
9 quarters
|
|
5
Microsoft
MSFT
$4.01T
| $10.8M | 2.59% |
243,902
-2,224
| -0.9% | -$99.9K |
2013 Q2
9 quarters
|
|
6
Altria Group
MO
$123B
| $10.3M | 2.48% |
190,103
-51,551
| -21% | -$2.76M |
2013 Q2
9 quarters
|
|
7
American International
AIG
$41.4B
| $10.3M | 2.48% |
181,584
-1,513
| -0.8% | -$92.5K |
2014 Q1
6 quarters
|
|
8
JPMorgan Chase
JPM
$891B
| $10.2M | 2.44% |
166,941
-2,477
| -1% | -$162K |
2013 Q2
9 quarters
|
|
9
Johnson & Johnson
JNJ
$610B
| $9.88M | 2.37% |
105,877
-747
| -0.7% | -$72.3K |
2013 Q2
9 quarters
|
|
10
Honeywell
HON
$66.7B
| $9.86M | 2.37% |
115,861
-1,671
| -1% | -$152K |
2013 Q2
9 quarters
|
|
|
BHI
11
DELISTED
Baker Hughes
BHI
| $9.66M | 2.32% |
185,606
-1,568
| -0.8% | -$87.6K |
2013 Q2
9 quarters
|
|
12
Teva Pharmaceutical Industries Limited
TEVA
$47.9B
| $9.56M | 2.29% |
169,244
-3,061
| -2% | -$198K |
2013 Q2
9 quarters
|
|
13
Cisco
CSCO
$433B
| $9.38M | 2.25% |
357,411
-681
| -0.2% | -$18.4K |
2013 Q2
9 quarters
|
|
14
DuPont de Nemours
DD
$17.8B
| $9.25M | 2.22% |
86,113
-385
| -0.4% | -$44.6K |
2013 Q4
7 quarters
|
|
15
Merck
MRK
$358B
| $9M | 2.16% |
191,064
-1,144
| -0.6% | -$60.8K |
2013 Q2
9 quarters
|
|
16
United Parcel Service
UPS
$83.2B
| $8.96M | 2.15% |
90,765
-2,048
| -2% | -$202K |
2013 Q4
7 quarters
|
|
17
Oracle
ORCL
$408B
| $8.72M | 2.09% |
241,327
-333
| -0.1% | -$12.8K |
2013 Q2
9 quarters
|
|
18
Procter & Gamble
PG
$365B
| $8.53M | 2.05% |
118,545
-157
| -0.1% | -$11.8K |
2013 Q2
9 quarters
|
|
19
Ford
F
$49.1B
| $8.26M | 1.98% |
608,297
-7,694
| -1% | -$110K |
2013 Q4
7 quarters
|
|
20
DELISTED
EMC CORPORATION
EMC
| $8.12M | 1.95% |
335,894
-3,176
| -0.9% | -$80.3K |
2013 Q2
9 quarters
|
|
|
21
Diageo
DEO
$52.3B
| $7.93M | 1.9% |
+73,562
| New | +$8.17M |
2015 Q3
0 quarters
|
|
22
Loews
L
$22.2B
| $7.82M | 1.88% |
216,475
-2,284
| -1% | -$85.4K |
2013 Q2
9 quarters
|
|
23
DELISTED
Anywhere Real Estate
HOUS
| $7.33M | 1.76% |
194,648
-4,500
| -2% | -$196K |
2013 Q2
9 quarters
|
|
|
RDS.A
24
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $6.92M | 1.66% |
154,071
-1,256
| -0.8% | -$63.8K |
2013 Q2
9 quarters
|
|
25
Macy's
M
$6.33B
| $6.92M | 1.66% |
134,762
-245
| -0.2% | -$15.4K |
2015 Q1
2 quarters
|
|
Similar funds
BI
GCM
GWAG
BRIM
PPW
OCAM
AAS
TAWM
Strategy Asset Managers's Q3 2015 Portfolio in Review
As of Q3 2015, Strategy Asset Managers held 158 positions worth $417M, down 7.1% from $448M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Strategy Asset Managers's Q3 2015 filing shows 25 new, 28 increased, 58 reduced and 26 closed positions. Its largest new stake was Diageo: 73,562 shares worth $7.93M. The largest sale was Lockheed Martin, an estimated $3.69M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Technology and Industrials.
- Strategy Asset Managers's largest Q3 2015 buy was Diageo: 73,562 shares worth $7.93M.
- Strategy Asset Managers added most to Eli Lilly in Q3 2015, an estimated $2.1M increase.
- Strategy Asset Managers's biggest Q3 2015 reduction was Lockheed Martin, cutting an estimated $3.69M.
- Strategy Asset Managers fully exited General Dynamics in Q3 2015, selling an estimated $3.51M.
- Strategy Asset Managers's ten largest holdings make up 26% of its $417M portfolio in Q3 2015.
- Strategy Asset Managers opened 25 new positions and closed 26 in Q3 2015.
- Strategy Asset Managers's portfolio value fell 7.1% quarter-over-quarter to $417M.
Based on Strategy Asset Managers's 13F filing for Q3 2015, filed 5 Nov 2015.